Literature DB >> 4300897

Susceptibility of salmonellae to cephalosporins and to nine other antimicrobial agents.

R Adams, J D Nelson.   

Abstract

Three cephalosporin-related antibiotics and nine other antimicrobial agents were studied for in vitro effectiveness against 54 recently isolated strains of Salmonella. Minimal inhibitory concentrations determined by the plate dilution method demonstrated the following percentages of resistance: ampicillin, 6%; tetracycline, 13%; streptomycin, 52%; sulfadiazine, 94%; cephaloglycin, 96%; and lincomycin, 100%. No strains were resistant to cephalothin, cephaloridine, chloramphenicol, colistimethate, kanamycin, and polymyxin B. The commonest serotype studied, S. typhimurium, showed the greatest antibiotic resistance, with 21% resistant to ampicillin, 36% resistant to tetracycline, and 71% resistant to streptomycin. Cephalothin and cephaloridine were highly effective in vitro but inhibitory concentrations of 20 to 40 mug of cephaloglycin per ml were required for the majority of Salmonella strains.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4300897      PMCID: PMC547705          DOI: 10.1128/am.16.10.1570-1574.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  18 in total

1.  Failure of kanamycin in the treatment of typhoid fever.

Authors:  H D RILEY; N J RYAN
Journal:  J Pediatr       Date:  1961-08       Impact factor: 4.406

2.  Cephaloridine and cephalothin comparative in vitro evaluation.

Authors:  R L Perkins; S Saslaw; J Hackett
Journal:  Am J Med Sci       Date:  1967-03       Impact factor: 2.378

3.  Cephaloridine. Studies of therapeutic activity and untoward effects.

Authors:  K Kaplan; B Reisberg; L Weinstein
Journal:  Arch Intern Med       Date:  1968-01

4.  Antibiotic susceptibility of Listeria monocytogenes and treatment of neonatal listeriosis with ampicillin.

Authors:  J D Nelson; S Shelton; D Parks
Journal:  Acta Paediatr Scand       Date:  1967-03

5.  Clinical evaluation of cephaloridine.

Authors:  N H Steigbigel; J W Kislak; J G Tilles; M Finland
Journal:  Arch Intern Med       Date:  1968-01

6.  In-vitro susceptibility of E. coli, Shigellae and Salmonellae to kanamycin and therapeutic implications.

Authors:  J D Nelson; K C Haltalin
Journal:  Ann N Y Acad Sci       Date:  1966-06-14       Impact factor: 5.691

7.  Cephaloridine treatment of bacterial infections.

Authors:  M A Apicella; R L Perkins; S Saslaw
Journal:  Am J Med Sci       Date:  1966-03       Impact factor: 2.378

8.  Clinical experience with cephaloridine.

Authors:  W J Holloway; E G Scott
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

9.  Laboratory and clinical evaluation of cephaloridine, a cephalosporin derivative.

Authors:  P E Hermans; J K Martin; G M Needham; D R Nichols
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

10.  Nephrotoxicity associated with the use of cephaloridine.

Authors:  A R Hinman; E Wolinsky
Journal:  JAMA       Date:  1967-05-22       Impact factor: 56.272

View more
  1 in total

1.  Bactericidal activities of chloramphenicol and eleven other antibiotics against Salmonella spp.

Authors:  S R Preblud; C J Gill; J M Campos
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.